Tyra Biosciences Inc. (TYRA)
NASDAQ: TYRA
· Real-Time Price · USD
12.54
-0.22 (-1.72%)
At close: Sep 25, 2025, 3:59 PM
12.54
0.00%
After-hours: Sep 25, 2025, 04:18 PM EDT
-1.72% (1D)
Bid | 12.29 |
Market Cap | 668.33M |
Revenue (ttm) | 496K |
Net Income (ttm) | -105.83M |
EPS (ttm) | -1.79 |
PE Ratio (ttm) | -7.01 |
Forward PE | -5.84 |
Analyst | Buy |
Dividends | n/a |
Ask | 13.2 |
Volume | 82,298 |
Avg. Volume (20D) | 257,276 |
Open | 12.66 |
Previous Close | 12.76 |
Day's Range | 12.40 - 12.76 |
52-Week Range | 6.42 - 29.60 |
Beta | 1.10 |
Ex-Dividend Date | n/a |
About TYRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TYRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TYRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+14.26%
Tyra Biosciences shares are trading higher after t...
Unlock content with
Pro Subscription
11 months ago
-23.35%
Tyra Biosciences shares are trading lower. The company announced clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial cancer from its ongoing SURF301 Phase 1/2 study.